• Hims & Hers Health (NYSE:HIMS) has introduced a new monthly Weight Loss Membership that offers more flexible access to GLP-1 treatments and ongoing medical support.
• The company has completed its acquisition of Eucalyptus, adding operations in markets such as Germany, Australia, and Japan and expanding its telehealth reach.
• These moves represent a shift in how Hims & Hers approaches weight management and global online care, with potential implications for its customer base and service mix.

Hims & Hers Health is making these changes while its stock trades at $27.78. The share price is down 16.9% year to date and down 51.7% over the past year, and the 3-year return is reported at about 3.2x and the 5-year return at 136.0%. For investors tracking NYSE:HIMS, the company now combines a lower-commitment weight loss offer with expanded international reach.

These updates draw more attention to how Hims & Hers balances weight management offerings with broader telehealth services in multiple regions. As regulatory and competitive conditions for online healthcare and peptides continue to change, the new membership structure and Eucalyptus integration could influence how consistently customers use the platform and how the business mix develops over time.

Stay updated on the most important news stories for Hims & Hers Health by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Hims & Hers Health.

Investor Checklist

Quick Assessment

• ❌ Price vs Analyst Target: At US$27.78, the stock trades about 4.4% above the US$26.61 analyst price target, with a target range of US$21 to US$35.
• ❌ Simply Wall St Valuation: Shares are described as trading at a very large premium, about 620.5% above the estimated fair value.
• ❌ Recent Momentum: The stock is down 4.7% over the last 30 days, pointing to recent weakness despite the new initiatives.

There's only one way to know the right time to buy, sell or hold Hims & Hers Health. Head to Simply Wall St's company report for the latest analysis of Hims & Hers Health's Fair Value.

Key Considerations

• 📊 The Weight Loss Membership and Eucalyptus deal shift the mix toward subscription style weight care and broader international telehealth access, which could change revenue drivers over time.
• 📊 Watch member uptake for GLP 1 programs, contribution from new markets such as Germany, Australia and Japan, and any updates to revenue and earnings guidance tied to these rollouts.
• ⚠️ With one flagged risk on share price volatility and a valuation that screens as very stretched, position sizing and time horizon become especially important for anyone considering exposure here.

Dig Deeper

For the full picture including more risks and rewards, check out the complete Hims & Hers Health analysis. Alternatively, you can check out the community page for Hims & Hers Health to see how other investors believe this latest news will impact the company's narrative.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.